Propanc Biopharma Targets Site of First-In-Human Study for PRP at the Peter Mac Cancer Center, Melbourne, Australia
Initial Discussion Held with Clinical Investigator at Australia’s Biggest Cancer Hospital
United States Mark Rosenthal Peter Mac James Nathanielsz Company Mechanism Of Action Peter Mac Cancer Center
Source: ibtimes.com.au